Skip to main content

Daniel Gauthier

Items from 29 people Daniel Gauthier follows

Ken Adams

Bet On Sports With My Sure-Money System And Win 97% Of Your Bets! | Insurance Appointment Setting

Affiliates Earn $100 Per Sale! Here Are My 97% Win-rate Football, Baseball And Basketball Betting Systems That Ive

Shared by Ken Adams, 1 save total

Matti Narkia

Plasma Selenium, Manganese Superoxide Dismutase, and Intermediate- or High-Risk Prostate Cancer -- Chan et al., 10.1200/JCO.2008.18.8938 -- Journal of Clinical Oncology

Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer.
Chan JM, Oh WK, Xie W, Regan MM, Stampfer MJ, King IB, Abe M, Kantoff PW.
J Clin Oncol. 2009 Aug 1;27(22):3577-83. Epub 2009 Jun 15.
PMID: 19528373
DOI: 10.1200/JCO.2008.18.8938

Conclusion: These data suggest that the relationship between circulating selenium levels at diagnosis and prognostic risk of prostate cancer is modified by SOD2 genotype and indicate caution against broad use of selenium supplementation for men with prostate cancer.

Shared by Matti Narkia, 1 save total

Matti Narkia

Selenium may worsen prostate cancer in some men - MedWire News - Consumer Health

"MedWire News: High levels of selenium in the blood may worsen prostate cancer in some men who already have the disease, results of a US study suggest.

In recent years, selenium supplements have been promoted as a means of preventing prostate cancer, largely based on observational studies that found higher prostate cancer incidence and mortality in geographical areas that are naturally low in selenium, compared with in those that are naturally high in the mineral.

However, the current research findings suggest that “if you already have prostate cancer, it may be a bad thing to take selenium,” said study researcher Dr Philip Kantoff, from the Dana-Farber Cancer Institute in Boston, Massachusetts, USA."

Shared by Matti Narkia, 1 save total

Matti Narkia

Natural Sphingadienes Inhibit Akt-Dependent Signaling and Prevent Intestinal Tumorigenesis -- Fyrst et al., 10.1158/0008-5472.CAN-09-2341 -- Cancer Research

Natural Sphingadienes Inhibit Akt-Dependent Signaling and Prevent Intestinal Tumorigenesis.
Fyrst H, Oskouian B, Bandhuvula P, Gong Y, Byun HS, Bittman R, Lee AR, Saba JD.
Cancer Res. 2009 Nov 24. [Epub ahead of print]
PMID: 19934323
DOI: 10.1158/0008-5472.CAN-09-2341

Shared by Matti Narkia, 1 save total

Matti Narkia

Sham vs. Wham: The Health Insider: Soy Products May be Important for Fighting Colon Cancer

"Scientists at the Children’s Hospital & Research Center in Oakland, California, have identified a new class of therapeutic agents found naturally in soy that can prevent and possibly treat colon cancer, the third most deadly form of cancer. "Sphingadienes" (SDs) are natural lipid molecules found in soy that research shows may be the key to fighting colon cancer.

The study, led by Dr. Julie Saba, director of the Cancer Center at Children’s Hospital Oakland, will be published in the December 15, 2009 issue of Cancer Research. Soy has long been touted as protective against colon cancer, but Dr. Saba’s team made the groundbreaking discovery that SDs naturally found in soy may underlie the benefits of soy products. It is important for science to find the mechanism of action behind a natural product claim on something like this -- it lends much more credibility to the concept."

Shared by Matti Narkia, 1 save total

Matti Narkia

The Heart Scan Blog: This is your brain on wheat

"Here's just a smattering of the studies performed over the past 30 years on the psychological effects of wheat consumption.

Oddly, this never makes the popular press. But wheat underlies schizophrenia, bipolar illness, behavioral outbursts in autism, Huntington's disease, and attention deficit hyperactivity disorder (ADHD).

The relationship is especially compelling with schizophrenia:

Opioid peptides derived from food proteins: The exorphins.
Zioudrou C et al 1979
"Wheat gluten has been implicated by Dohan and his colleagues in the etiology of schizophrenia and supporting evidence has been provided by others. Our experiments provide a plausible biochemical mechanism for such a role, in the demonstration of the conversion of gluten into peptides with potential central nerovus system actions." "

Shared by Matti Narkia, 1 save total

Matti Narkia

Novel Formulation Of Vitamin E Extract Could Tackle Tumors Without Damaging Healthy Tissue

A new formulation of the vitamin E extract tocotrienol could play a key role in treating cancerous tumors without harming healthy tissue. Tocotrienol has anti-cancer properties, but when given intravenously it has secondary effects on healthy tissue; now researchers in the UK have found that delivering the compound encapsulated in transferrin-bearing vesicles can shrink tumors without causing visible toxic effects.

Shared by Matti Narkia, 1 save total

Matti Narkia

Soy compounds may not prevent bone loss: MedlinePlus

"Wednesday, December 9, 2009

By Amy Norton

NEW YORK (Reuters Health) - Supplements containing soy isoflavones may do little to preserve women's bone mass after menopause.

In a study of more than 200 women ages 46 to 65, researchers found that the soy supplement did not appear to ward off bone-density loss over 3 years. In general, women on the supplement showed the same degree of bone loss as those given a placebo -- though there was some evidence that a higher dose helped protect bone density in the hip.

The findings, reported in the American Journal of Clinical Nutrition, add to a conflicting body of research on soy and postmenopausal bone health.

Some studies have suggested that soy-based foods, isolated soy protein or isoflavone-containing supplements may be beneficial, while others have found no advantage.

Isoflavones are natural chemicals found in soybeans and certain other plant foods that are structurally similar to estrogen, and may have certain estrogen-like effects in the human body. Since declining estrogen levels after menopause spur bone-density loss, isoflavone supplements could theoretically protect women's bone mass.

The current findings, however, do not support that theory."

Shared by Matti Narkia, 1 save total

Matti Narkia

Obesity linked with poorer breast cancer outcomes

"SAN ANTONIO – Breast cancer patients with a high body mass index (BMI) have a poorer cancer prognosis later in life. Specifically, their treatment effect does not last as long and their risk of death increases.

"Overall, women should make an effort to keep their BMI less than 25," said Marianne Ewertz, M.D., professor in the Department of Oncology at Odense University Hospital, Denmark. "Those who have a high BMI should be encouraged to participate in mammography screening programs for prevention efforts.""

Shared by Matti Narkia, 1 save total

Show more recent items

Diigo is about better ways to research, share and collaborate on information. Learn more »

Join Diigo